BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7878538)

  • 1. Selective inhibition of cyclic adenosine monophosphate-mediated pulmonary vasodilation by acute hypoxia.
    McIntyre RC; Banerjee A; Hahn AR; Agrafojo J; Fullerton DA
    Surgery; 1995 Mar; 117(3):314-8. PubMed ID: 7878538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung transplantation with cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung.
    Fullerton DA; McIntyre RC; Mitchell MB; Campbell DN; Grover FL
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):212-6; discussion 216-7. PubMed ID: 7853874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold ischemia and reperfusion each produce pulmonary vasomotor dysfunction in the transplanted lung.
    Fullerton DA; Mitchell MB; McIntyre RC; Banerjee A; Campbell DN; Harken AH; Grover FL
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1213-7. PubMed ID: 8246563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Am J Physiol; 1997 Nov; 273(5):L950-6. PubMed ID: 9374721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
    Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
    Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow.
    Fullerton DA; Mitchell MB; Jones DN; Maki A; McIntyre RC
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):190-7. PubMed ID: 8551766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
    Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
    Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility.
    McIntyre RC; Banerjee A; Agrafojo J; Fullerton DA
    J Surg Res; 1995 Jun; 58(6):765-70. PubMed ID: 7791358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin differentially impairs cyclic guanosine monophosphate-mediated relaxation in the pulmonary and systemic circulations.
    McIntyre RC; Sheridan B; Agrafojo J; Fullerton DA
    Crit Care Med; 1997 Feb; 25(2):318-23. PubMed ID: 9034271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indigo carmine inhibits endothelium-dependent and -independent vasodilation.
    Chang KS; Zhong MZ; Davis RF
    Hypertension; 1996 Feb; 27(2):228-34. PubMed ID: 8567045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.
    Fullerton DA; Hahn AR; Banerjee A; Harken AH
    J Surg Res; 1994 Aug; 57(2):259-63. PubMed ID: 7913147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium is essential in mechanisms of pulmonary vasomotor control.
    Fullerton DA; Hahn AR; Agrafojo J; Sheridan BC; McIntyre RC
    J Surg Res; 1996 Jun; 63(1):93-7. PubMed ID: 8661179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery.
    Rodman DM; Yamaguchi T; Hasunuma K; O'Brien RF; McMurtry IF
    Am J Physiol; 1990 Apr; 258(4 Pt 1):L207-14. PubMed ID: 2159226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
    Toyoshima H; Nasa Y; Hashizume Y; Koseki Y; Isayama Y; Kohsaka Y; Yamada T; Takeo S
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury.
    Fullerton DA; Hahn AR; McIntyre RC
    Surgery; 1996 Jan; 119(1):98-103. PubMed ID: 8560394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
    Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
    Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Agrafojo J; Meldrum DR; Meng X; Fullerton DA
    Am J Physiol; 1996 Nov; 271(5 Pt 1):L820-8. PubMed ID: 8944726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular mechanisms of pulmonary vasomotor dysfunction in acute lung injury caused by mesenteric ischemia-reperfusion.
    Fullerton DA; Hahn AR; Koike K; Banerjee A; Harken AH
    Surgery; 1993 Aug; 114(2):360-6; discussion 366-7. PubMed ID: 8393598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1999 May; 127(1):291-9. PubMed ID: 10369485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
    Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
    Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.